Institutions / Cormorant Asset Management, LP
Cormorant Asset Management, LP
CIK 1583977 · Institution · as of Dec 31, 2025
Portfolio value
$1.76B
Positions
32
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 32 →
| Company | Value | % of portfolio |
|---|---|---|
| Praxis Precision Medicines, Inc. | $280.00M | 15.9% |
| BridgeBio Oncology Therapeutics, Inc.BBOT | $223.84M | 12.7% |
| Abivax SA | $182.05M | 10.3% |
| EyePoint, Inc. | $151.00M | 8.6% |
| Rapport Therapeutics, Inc.RAPP | $91.85M | 5.2% |
| BridgeBio Pharma, Inc. | $91.79M | 5.2% |
| Bright Minds Biosciences Inc. | $82.67M | 4.7% |
| Edgewise Therapeutics, Inc. | $81.52M | 4.6% |
| Olema Pharmaceuticals, Inc. | $68.75M | 3.9% |
| MoonLake ImmunotherapeuticsMLTX | $57.40M | 3.3% |
| Insmed Inc | $47.86M | 2.7% |
| enGene Therapeutics Inc. | $36.12M | 2.0% |
| Alumis Inc.ALMS | $35.48M | 2.0% |
| MBX Biosciences, Inc.MBX | $35.32M | 2.0% |
| Newamsterdam Pharma Company | $35.08M | 2.0% |
| Centessa Pharmaceuticals PLC | $33.14M | 1.9% |
| Pharvaris N.V. | $30.05M | 1.7% |
| BioAge Labs, Inc.BIOA | $27.00M | 1.5% |
| Ascendis Pharma A/S | $21.32M | 1.2% |
| Tarsus Pharmaceuticals, Inc. | $20.47M | 1.2% |
| Corbus Pharmaceuticals Holdings, Inc.CRBP | $19.09M | 1.1% |
| Gh Research PLC | $16.51M | 0.9% |
| Oruka Therapeutics, Inc. | $16.17M | 0.9% |
| Arcutis Biotherapeutics, Inc. | $14.52M | 0.8% |
| Crinetics Pharmaceuticals, Inc. | $13.96M | 0.8% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.